Merck finalizes $41 billion merger with Schering-Plough
Merck & Co. completed its $41 billion takeover of Schering-Plough, allowing the companies to begin operating as one entity today. The consolidation is expected to dramatically boost Merck's global expansion while bringing in a diverse pipeline of treatments, including those for cancer, women's health and infectious diseases.
Google
| 11/3
This story published in FMI Pharmacy dailyLead on 11/04/2009
Get stories like these delivered daily for FREE:
|
FMI Pharmacy dailyLead
Designed specifically for pharmacy professionals, FMI Pharmacy dailyLead is a FREE, daily e-mail newsletter. It provides the latest news in the pharmacy arena. Learn more |
|